Courses   Wikipedia   PubMed   Dictionary  
Username:
Password:
 
Create a CME-TODAY Account
Free Subscription
 You are here:   CME-TODAY Home  >>   Program CD0140  >>   Course AB0588
ACCREDITATION
CERTIFICATE FEES
You will need:

Instant Replay: Understanding ADHD in Adult Patients
Feedback
FAQ
INSTANT REPLAY

(Course AB0588)


This instant replay features a lively discussion about the diagnosis and treatment of ADHD.

Faculty: David Baron, MSEd, DO and Jay Fawver, MD

Recorded Live:
Wednesday, August 6, 2008

Wednesday, November 12, 2008


Please review this page completely before starting this course. Links to the course options can be found at the bottom of this page.

Key Words: ADHD, Adult ADHD, Performance Improvement, PDSA, Evaluation, Treatment, Patient Case, Primary Care
OVERVIEW
In this Instant Replay, David Baron, MSEd, DO and Jay Fawver, MD lead a case-based discussion showing best practices for recognizing ADHD in adult patients. You will find out about available diagnostic tools for identifying ADHD, brainstorm sensitive approaches to overcoming common barriers to care, and review common comorbid conditions.
[Top]
OBJECTIVES
  • Cite common presentations of attention-deficit/ hyperactivity disorder (ADHD) in adults

  • Identify the role of patient education in caring for the patient with ADHD

[Top]
TARGET AUDIENCE
This CME activity is designated for doctors of osteopathic medicine, primary care physicians, nurse practitioners, physician assistants, and other healthcare professionals who treat patients with ADHD.
[Top]
FACULTY
David Baron, MSEd, DO  [BioSketch]
Professor & Chair, Temple University School of Medicine, Department of Psychiatry, Philadelphia, PA
Disclosure: Speaker and consultant: Eli Lilly and Company; Advisor: Osmotica Pharmaceutical
Jay D. Fawver, MD  [BioSketch]
President and Medical Director, Fawver Wellness Clinic; President, Psychiatric Innovations, PC, Fort Wayne, Indiana; Clinical Professor of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana
Disclosure: Speaker Bureau and Consultant: Eli Lilly and Company, Pfizer Inc.
[Top]
CONFLICT OF INTEREST RESOLUTION

MEBN's mission is to provide medical education that is accurate, fair-balanced, unbiased and evidence-based. MEBN strives to ensure that every educational activity maintains independence, objectivity and scientific rigor. All faculty participating in these activities are expected to disclose any (or no) relevant financial interest or other relationship with (1) the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in any educational presentation, and/or (2) with any commercial supporters of an activity. Disclosure of these relationship(s) will be listed prior to any educational activity.

All apparent conflicts of interest have been identified and resolved through MEBN’s independent, peer-review process. Our intent is to assist learners in assessing the potential for bias in information that is presented during the educational activity. The faculty are also aware of their responsibility to inform the audience if discussion of any non-FDA-approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation. Unless otherwise indicated, MEBN staff and writers have no financial relationships with a commercial party to disclose.

Unless otherwise indicated, MEBN staff and writers have no financial relationships with a commercial party to disclose.

[Top]
Accreditation Statement
 
Continuing Medical Education for Physicians
Accreditation Statement
MEBN is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
CME Credits
MEBN designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
FDA Disclosure Statement
The contents of some CME activities may contain discussions of non-approved or off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
 
Accreditation Period
Original Release Date: September 2, 2008
Review Date: December 31, 2009
Expiration Date: December 31, 2011
 
Any questions regarding the accreditation of this CME activity should be directed to MEBN. (accreditation@mebn.net)
[Top]
DISCLAIMER

This continuing education program may contain discussion of published and/or investigational uses of agents or products that are not approved by the Food and Drug Administration (FDA). The authors, sponsors or publishers do not recommend the use of any agent or product outside of the official labeled indications. Please refer to the official prescribing information for each agent or product for discussion of approved indications, contraindications, and written warnings.

Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this course should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The authors, contributors, and editorial staff have made every effort to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, MEBN will be pleased to make the necessary and reasonable arrangements.

[Top]
 
Certificate Fees

CME-TODAY offers FREE continuing medical education (CME) credits to recipients of the CD-ROM, program emails or CME-TODAY journal. Enter the CE Code listed on the CD-ROM, in the email or in the journal when prompted. This free offer expires on December 31, 2010. All others will be assessed a $0.00 processing fee.

[Top]
HOW TO TAKE THIS COURSE

Choose Your Format To Begin Course:   


Audio
 
Multimedia
 
Podcast
 
Print
 
[Top]